Log In Sign up
The largest database of trusted experimental protocols

Clone ps1

Manufactured by Leica
Visit Supplier
Sourced in United Kingdom

The Clone PS1 is a compact and versatile laboratory equipment designed for scientific applications. It serves as a universal power supply, providing a stable and reliable source of electrical power for a variety of laboratory instruments and devices. The Clone PS1 is a compact and lightweight device, making it easily portable and suitable for use in various laboratory settings.

Automatically generated - may contain errors

Lab products found in correlation

Clone 4b11, by Leica (2 mentions) Clone fm264g, by BioLegend (2 mentions)

Close spelling variants of this product

CD3 (clone PS1; (3 citations) Anti-CD3 (clone PS1; (2 citations)

2 protocols using clone ps1

1

Tissue Culture of Resected Specimens

Check if the same lab product or an alternative is used in the 5 most similar protocols
As described previously75 (link), resected specimens were used for culture treatment. Briefly, the resected specimen rapidly was transferred into the lab in a sterile container, cut (size approximately 5 x 3 x 1 mm) and treated with respectively labelled and genetically modified cells. After culturing, the tissue was harvested and sectioned, subsequently being stained for human CD3epsilon (1:100 dilution, clone PS1, Novocastra, UK), CD8 (1:100 dilution, clone 4B11, Novocastra, UK) and for migrated cells a monoclonal anti-GFP antibody (clone FM264G, Biolegend) was used. Quantification was performed on whole slide sections as described previously76 (link). All material was obtained after approval by the medical ethics committee of the University of Heidelberg (S-069), written consent was obtained from all patients prior to analysis.
Lesch S., Blumenberg V., Stoiber S., Gottschlich A., Ogonek J., Cadilha B.L., Dantes Z., Rataj F., Dorman K., Lutz J., Karches C.H., Heise C., Kurzay M., Larimer B.M., Grassmann S., Rapp M., Nottebrock A., Kruger S., Tokarew N., Metzger P., Hoerth C., Benmebarek M.R., Dhoqina D., Grünmeier R., Seifert M., Oener A., Umut Ö., Joaquina S., Vimeux L., Tran T., Hank T., Baba T., Huynh D., Megens R.T., Janssen K.P., Jastroch M., Lamp D., Ruehland S., Di Pilato M., Pruessmann J.N., Thomas M., Marr C., Ormanns S., Reischer A., Hristov M., Tartour E., Donnadieu E., Rothenfusser S., Duewell P., König L.M., Schnurr M., Subklewe M., Liss A.S., Halama N., Reichert M., Mempel T.R., Endres S, & Kobold S. (2021). T cells armed with the C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours. Nature biomedical engineering, 5(11), 1246-1260.
+ Open protocol
+ Expand
2

Tissue Culture of Resected Specimens

Check if the same lab product or an alternative is used in the 5 most similar protocols
As described previously75 (link), resected specimens were used for culture treatment. Briefly, the resected specimen rapidly was transferred into the lab in a sterile container, cut (size approximately 5 x 3 x 1 mm) and treated with respectively labelled and genetically modified cells. After culturing, the tissue was harvested and sectioned, subsequently being stained for human CD3epsilon (1:100 dilution, clone PS1, Novocastra, UK), CD8 (1:100 dilution, clone 4B11, Novocastra, UK) and for migrated cells a monoclonal anti-GFP antibody (clone FM264G, Biolegend) was used. Quantification was performed on whole slide sections as described previously76 (link). All material was obtained after approval by the medical ethics committee of the University of Heidelberg (S-069), written consent was obtained from all patients prior to analysis.
Lesch S., Blumenberg V., Stoiber S., Gottschlich A., Ogonek J., Cadilha B.L., Dantes Z., Rataj F., Dorman K., Lutz J., Karches C.H., Heise C., Kurzay M., Larimer B.M., Grassmann S., Rapp M., Nottebrock A., Kruger S., Tokarew N., Metzger P., Hoerth C., Benmebarek M.R., Dhoqina D., Grünmeier R., Seifert M., Oener A., Umut Ö., Joaquina S., Vimeux L., Tran T., Hank T., Baba T., Huynh D., Megens R.T., Janssen K.P., Jastroch M., Lamp D., Ruehland S., Di Pilato M., Pruessmann J.N., Thomas M., Marr C., Ormanns S., Reischer A., Hristov M., Tartour E., Donnadieu E., Rothenfusser S., Duewell P., König L.M., Schnurr M., Subklewe M., Liss A.S., Halama N., Reichert M., Mempel T.R., Endres S, & Kobold S. (2021). T cells armed with the C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours. Nature biomedical engineering, 5(11), 1246-1260.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!